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Abstract
Background: Comprehensive and contemporary estimates of the number of pregnancies at risk of malaria are not currently
available, particularly for endemic areas outside of Africa. We derived global estimates of the number of women who
became pregnant in 2007 in areas with Plasmodium falciparum and P. vivax transmission.
Methods and Findings: A recently published map of the global limits of P. falciparum transmission and an updated map of
the limits of P. vivax transmission were combined with gridded population data and growth rates to estimate total
populations at risk of malaria in 2007. Country-specific demographic data from the United Nations on age, sex, and total
fertility rates were used to estimate the number of women of child-bearing age and the annual rate of live births.
Subregional estimates of the number of induced abortions and country-specific stillbirths rates were obtained from recently
published reviews. The number of miscarriages was estimated from the number of live births and corrected for induced
abortion rates. The number of clinically recognised pregnancies at risk was then calculated as the sum of the number of live
births, induced abortions, spontaneous miscarriages, and stillbirths among the population at risk in 2007. In 2007, 125.2
million pregnancies occurred in areas with P. falciparum and/or P. vivax transmission resulting in 82.6 million live births. This
included 77.4, 30.3, 13.1, and 4.3 million pregnancies in the countries falling under the World Health Organization (WHO)
regional offices for South-East-Asia (SEARO) and the Western-Pacific (WPRO) combined, Africa (AFRO), Europe and the
Eastern Mediterranean (EURO/EMRO), and the Americas (AMRO), respectively. Of 85.3 million pregnancies in areas with P.
falciparum transmission, 54.7 million occurred in areas with stable transmission and 30.6 million in areas with unstable
transmission (clinical incidence ,1 per 10,000 population/year); 92.9 million occurred in areas with P. vivax transmission,
53.0 million of which occurred in areas in which P. falciparum and P. vivax co-exist and 39.9 million in temperate regions
with P. vivax transmission only.
Conclusions: In 2007, 54.7 million pregnancies occurred in areas with stable P. falciparum malaria and a further 70.5 million
in areas with exceptionally low malaria transmission or with P. vivax only. These represent the first contemporary estimates
of the global distribution of the number of pregnancies at risk of P. falciparum and P. vivax malaria and provide a first step
towards a more informed estimate of the geographical distribution of infection rates and the corresponding disease burden
of malaria in pregnancy.
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Introduction
Malaria in pregnancy can have devastating consequences to a
pregnant woman and the developing fetus, but comprehensive
estimates of the annual number of women who become pregnant
each year in malaria endemic areas and are therefore at risk of
malaria are not available, particularly for Latin America and the
Asia-Pacific regions. These figures are an important first step
towards informing policy makers and for estimating the regional
needs for therapeutic and disease prevention tools for malaria in
pregnancy. The most cited global estimate is from the Roll Back
Malaria Partnership, which states that ‘‘each year approximately
50 million women living in malaria endemic countries throughout
the world become pregnant’’ [1]. However, an explanation of the
methods used to derive these estimates is not provided. More
comprehensive estimates exist for Africa and are provided by the
Africa Regional Office (AFRO) of the World Health Organization
(WHO) in their widely quoted strategic framework document for
malaria prevention and control during pregnancy in the African
region [2]. Their estimate of 24.6 million pregnancies at risk of
malaria (predominantly P. falciparum), is based on the number of
live born babies delivered in malarious areas of Africa in the year
2000 using a combination of malaria risk maps [3] and estimates
of the number of live births from UNICEF [4]. A more recent
estimate by the WHO states that ‘‘In Africa, 30 million women
living in malaria endemic areas become pregnant each year’’ [5].
Estimates for outside of Africa are less clear, particularly for P.
vivax. P. vivax is the most widely distributed human malaria parasite
and co-occurs with P. falciparum in tropical areas but also occurs in
temperate regions outside the limits of P. falciparum transmission. It
is the major cause of malaria in much of Asia and Latin America
[6,7], and recent evidence has shown that P. vivax infections are far
from benign and can result in significant morbidity in pregnant
women with serious consequences for maternal and infant health
[8–10].
Here we define a global estimate of the number of pregnancies at
risk of P. falciparum and P. vivax malaria in 2007 by combining
malaria spatial limits developed by the Malaria Atlas Project (MAP;
www.map.ox.ac.uk), which define the total population at risk of
malaria [11], with country-specific demographic data on women of
childbearing age provided by the United Nations and published
data on induced abortions and spontaneous pregnancy loss.
Methods
Data Sources
The global limits of P. falciparum malaria. The initial
focus of the Malaria Atlas Project has been P. falciparum [12] due to
its global epidemiological significance [13] and better prospects for
its control and local elimination [14]. The global spatial limits of P.
falciparum malaria transmission in 2007 have recently been
mapped. This was done by triangulating data on transmission
exclusion using biological rules based on temperature and aridity
limits on the bionomics of locally dominant Anopheles vectors, data
on nationally reported case incidence rates, and other medical
intelligence [15]. The resulting map stratifies the malaria endemic
world by stable and unstable transmission in 2007 [15]. Unstable
transmission refers to areas where transmission is plausible
biologically, but limited, with a clinical incidence of less than
one case per 10,000 population per year. Stable transmission refers
to areas with a minimum of one clinical case per 10,000
population per year [15].
The global limits of P. vivax malaria. Initial attempts to
map the limits of P. falciparum and P. vivax transmission were made
by Guerra et al. [16,17]. The resulting maps and ‘‘masks’’
(mapped areas that are filtered and excluded from analyses) used
were later tested against the Malaria Atlas Project parasite
prevalence database to assess their feasibility [18,19]. This
testing revealed that the accuracy to define areas of zero
transmission risk due to very low population densities was
limited because of the coarse spatial resolution of the initial
map. Moreover, in the initial mapping [16,17], a high density
population mask was used on the basis of the assumption that no
transmission occurs in areas where the population density is so
high that conditions become unsuitable for transmission through
the process of urbanization. However, recent analyses [19] provide
evidence suggesting that high density population masks and urban
extent maps should not be used to map zero risk because some
transmission can occur in high density urban areas, although this is
significantly lower than in rural areas [18,19]. Therefore, for the
current analyses, the P. vivax limits were redefined using the same
methods as in Guerra et al. [16,17], but without applying the
population-based masks. Also, previously excluded P. vivax
endemic countries have now been added after a more extensive
review of the literature; these include Comoros, Djibouti,
Madagascar, and Uzbekistan. This refinement of the spatial
limits of transmission for P. vivax accounted for an approximate
19% increase in the population at risk (PAR) compared with
previous estimates [16,17], principally (18%) due to the inclusion
of major cities.
Gridded population data. The Global Rural-Urban
Mapping Project (GRUMP) alpha version provides gridded
population counts and population density estimates for the years
1990, 1995, and 2000, both adjusted and unadjusted to the United
Nations’ national population estimates [11,20]. The adjusted
population counts for the year 2000 were projected to 2007 by
applying national, medium variant, intercensal growth rates by
country [21] using methods described previously [22].
Annual number of pregnancies per country. The number
of pregnancies was calculated as the sum of the number of live
births, induced abortions, and spontaneous pregnancy loss
(including miscarriages and stillbirths) in 2007.
Live births. The annual number of live births in 2007 was
estimated per country using demographic data on the proportion
of women of childbearing age (WOCBAs) within a population and
the total fertility rates. The data were abstracted from the United
Nations’ national population estimates, which provide publicly
accessible demographic information by year, age, sex, and country
for Africa, Asia, and the Americas [23]. The number of WOCBAs
in each country, defined as the mid-year resident number of
women aged between 15 and 49y, was obtained for the years 2005
and 2010 (interim years are not available), and the number of
WOCBAs for 2007 was calculated as the midpoint between the
2005 and 2010 estimates. The fraction of WOCBAs per country
was then calculated as the number of WOCBAs in 2007 divided
by the mid-year resident population at risk in 2007 (available by
year).
The total fertility rate (TFR) is an age-standardised measure of
fertility and corresponds to the total number of children that
would be born alive to a woman entering her childbearing years at
age 15y if she lived to the end of her childbearing years (age 49y)
and if her fertility during these 35 reproductive years was the same
as the average woman of childbearing age. The total fertility rate
divided by 35 is the average number of live births per WOCBA
per year and when multiplied by 1,000 this is expressed as the rate
of live births per 1,000 WOCBAs per year.
Induced abortions, miscarriages, and stillbirth
rates. Subregional data on induced abortion rates were
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obtained from a recently published review that calculated the
worldwide, regional, and subregional incidence of safe and unsafe
abortions in women of child bearing age in 2003 by use of reports
from official national reporting systems, nationally representative
demographic health surveys, hospital data, other surveys, and
published studies [24].
Country-specific information on stillbirth rates was abstracted
from model-based estimates published by Stanton et al. [25] that
derived data from vital registration, demographic and health
surveys (DHS), and data from study reports integrated into a
regression model. Regional estimates were used for three malaria
endemic countries for which country-specific estimates were not
available (French Guiana, Mayotte, and Timor-Leste).
Country-specific data on miscarriages (spontaneous abortions)
are not available. To calculate the proportion of pregnancies
resulting in miscarriage, a method was applied that uses multipliers
to work backwards from the (known) number of live births and
induced abortions to recover the (unknown) underlying number of
pregnancies that ‘‘produced’’ them, as described in detail
previously [24,26–28]. The method takes account of pregnancies
that are terminated voluntarily during the period of risk for
miscarriage and estimates the number of spontaneous pregnancy
loss (stillbirths and miscarriages) as 10% of induced abortions plus
20% of live births. It is based on clinical studies of rates of
pregnancy loss by gestational age that indicate that for each 100
induced abortions an additional ten clinically recognised preg-
nancies will have aborted spontaneously prior to the average
gestational age of induced abortions in that population, and that
approximately 120 additional clinically recognised pregnancies are
required to ‘‘produce’’ 100 live births [27,28]. For example, in
Afghanistan it was estimated that in 2007 1.182 million live births
occurred among a population of 27 million and a further 0.284
million induced abortions occurred. The number of spontaneous
pregnancy losses (the sum of the number of stillbirths and
miscarriages) was therefore estimated at 0.261,182 plus
0.160.284= 0.265 million, and the total number of pregnancies
as 1.731 million. The reported number of miscarriages used in this
manuscript represents the number of spontaneous pregnancy
losses calculated through the multiplier method as described
above, minus the country-specific number of stillbirths obtained
from the review by Stanton et al. [25]. The estimates provided in
this study refer to clinically recognised pregnancies and do not take
into account the potentially large but unknown rates of embryonic
loss that may occur in the first 4–6 wk of gestation.
Estimating the annual number of pregnancies exposed to
malaria. To obtain the total population at risk, the limits of
stable and unstable P. falciparum transmission and the limits of P.
vivax transmission described above were overlaid onto the Global
Rural-Urban Mapping Project (GRUMP) alpha surface, projected
to 2007. For every malaria endemic country of the world, the
population within each set of limits was extracted, following
approaches described previously [13]. The number of pregnancies
at risk of malaria was then calculated from the total annual
number of pregnancies estimated to have occurred in 2007 in the
entire country multiplied by the fraction of the total resident
population living within the spatial limits of malaria transmission
in that country.
Results
Tables 1 and 2 provide a summary of the total population living
within the global spatial limits of malaria transmission in 2007,
and the corresponding number of total population, pregnancies,
and live births, stratified by species and transmission patterns
(within areas of assumed unstable and stable P. falciparum
transmission), globally and by WHO region.
The compiled data showed that, globally, 125.2 million
women living in areas with P. falciparum and/or P. vivax
transmission became pregnant in 2007: 77.4 million (61.8%)
in the countries that fall under the regional office of the WHO
for the South East Asian (SEARO) and the Western Pacific
Region (WPRO); 30.3 million (24.2%) in AFRO; 13.1 million
(10.5%) in the Eastern Mediterranean and European Region
(EMRO and EURO); and only 4.3 million (3.4%) in the
American Region (AMRO) (Table 3). Figures 1 and 2 display
the same analysis by species, but depicted by continent rather
than by WHO region. Of the 125.2 million pregnancies, 82.6
million (66.0%) are estimated to result in live births; 48.8
million (63.0%), 22.1 million (72.7%), 9.0 million (68.8%), and
2.7 million (63.1%) in the SEARO/WPRO, AFRO, EMRO/
EURO, and AMRO regions, respectively (Table 4). It illustrates
that the proportional distribution of pregnancies at risk
resulting in live births is slightly different from the distribution
of total pregnancies at risk, primarily reflecting the differences
in the proportion of pregnancies ending in induced abortions,
which is much lower in the AFRO region (11.9%) compared to
the global average in the malaria endemic countries of 19.5%
[24].
Table 1. Demographic data for malaria endemic countries.
WHORO
Region
n of
MECs
Total Population
(Both Sexes)a WOCBAsa
Total n of
Pregnanciesb TPRc
Pregnancy Rate per
1,000 WOCBAs1 Percentage Pregnancies Ending in:
Live-
births
Still-
births
Spontaneous
Abortions
Induced
Abortions
AFRO 43 755 178 36 7.16 204 72.4% 2.3% 13.3% 11.9%
EMRO/EURO 19 544 142 19 4.76 136 68.8% 2.3% 13.1% 15.8%
AMRO 21 530 143 16 3.81 109 63.2% 0.9% 14.0% 22.0%
SEARO/WPRO 19 3,327 881 91 3.62 103 62.4% 1.6% 13.1% 22.8%
Global 102 5,157 1,343 162 4.23 121 65.5% 1.8% 13.3% 19.5%
aSource: United Nations Development Program (in millions).
bThe total number of pregnancies is the sum of the number of live-births, stillbirths, spontaneous, and induced abortions (in millions).
cThe total pregnancy rate (TPR) and the annual pregnancy rate per 1,000 WOCBAs are weighted means per region and is for illustration purposes only. The number of
pregnancies was derived directly as the sum of the national estimates within each region and globally.
MEC, malaria endemic countries; WHORO, World Health Organization Regional Office.
doi:10.1371/journal.pmed.1000221.t001
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P. falciparum Malaria
Of the 125.2 million pregnancies defined above, 85.3 million
occur in areas with P. falciparum transmission, 51.8% of them (44.2
million) are in the combined SEARO-WPRO regions and 35.1%
(30.0 million) in the AFRO region. The remainder live in the
EMRO-EURO (9.6%) and AMRO regions (3.5%) (Figure 3;
Table 3). As expected, the top five ranked countries with the
highest number of pregnancies at risk of P. falciparum malaria were
the malaria endemic countries with the largest overall populations:
India (28.2 million), Nigeria (6.5 million), Indonesia (4.4 million),
Pakistan (3.7 million), and the Democratic Republic of the Congo
(3.3 million). Overall, 64.1% of 85.3 million pregnancies at risk of
P. falciparum malaria live in areas with assumed stable transmission
(Figure 3). However, this varies widely by region; from 98.7% in
the AFRO region to none in the EURO region. As depicted in
Figure 3, 55.3% of the 44.2 million pregnancies at risk of P.
falciparum in the WPRO/SEARO region occur in areas of very low
and unstable transmission.
P. vivax Malaria
Globally, an estimated 92.9 million pregnancies occurred in
areas endemic for P. vivax in 2007 (including in areas where both P.
falciparum and P. vivax co-exist) (Figure 2). The top five ranked
countries include: India (32.9 million), China (21.2 million),
Indonesia (6.3 million), Pakistan (5.8 million), and Bangladesh (4.7
million). In the WPRO/SEARO region, where the majority of the
populations at risk of P. vivax live (Figure 4), approximately 98.2%
of those pregnancies in malaria endemic countries occur in areas
with P. vivax transmission (alone or combined with P. falciparum). By
contrast this was only 11.9% for the AFRO region where P. vivax
transmission is principally restricted to the horn of Africa region,
Madagascar, and the Comoros islands (Figure 4).
The country-specific demographic data and population at risk
estimates (Table S1), as well as total pregnancies at risk and by
specific pregnancy outcomes (live births, induced abortions,
stillbirths, and miscarriages; Table S2) and summary estimates
by other regional categories (continents instead of WHO regions;
Table S3), are provided as supplemental information. In addition,
information is provided illustrating which countries are included in
the different WHO regions (also see Figure S1) [29]. In brief, all
malaria endemic countries on the African continent fall under the
Africa Regional Office (AFRO), with the exception of Djibouti,
Somalia, and Sudan, which fall under the EMRO office.
Discussion
This is the first time, to our knowledge, that contemporary
species-specific estimates of the annual number of pregnancies at
risk of malaria globally have been made. Our findings suggest that
Table 2. Total population at risk of P. falciparum and/or P. vivax malaria by WHO regional office in 2007 (in millions) (percent of the
population in malaria endemic countries at risk).
WHORO Region P. falciparum Transmissiona P. vivax Transmissiona Any Species
Stable Transmissionb Unstable Transmissionb Overall Overall Overall
AFRO 599.9 (79.4) 8.4 (1.1) 607.8 (80.5) 73.2 (9.7) 615.4 (81.5)
EMRO/EURO 89.8 (16.5) 101.7 (18.7) 190.9 (35.1) 285.1 (52.4) 343.9 (63.2)
AMRO 41.2 (7.8) 50.2 (9.5) 91.4 (17.2) 96.2 (18.2) 138.2 (26.1)
SEARO/WPRO 654.9 (19.7) 824.9 (24.8) 1479.3 (44.5) 2,722.3 (81.8) 2,770.1 (83.3)
Global 1,385.8 (26.9) 985.1 (19.1) 2,369.4 (45.9) 3,176.9 (61.6) 3,867.6 (75.0)
Similar tables with risk estimates by continent and by pregnancy outcome (live-birth, induced abortions, stillbirths, and miscarriages) are provided in Tables S1, S2, S3.
aIncludes countries where P. falciparum and P. vivax co-exist.
bStable transmission, $1 autochthonous P. falciparum cases per 10,000 people per annum; unstable transmission, ,1 autochthonous P. falciparum cases per 10,000
people per annum [15].
MEC, malaria endemic countries; TPR, total pregnancy rate; WHORO, World Health Organization Regional Office.
doi:10.1371/journal.pmed.1000221.t002
Table 3. Number of pregnancies at risk of P. falciparum and/or P. vivax malaria by WHO regional office in 2007 (in millions)
(column %).
WHORO Region P. falciparum Transmissiona P. vivax Transmissiona Any Species
Stable Transmissionb Unstable Transmissionb Overall Overall Overall
AFRO 29.6 (54.1) 0.4 (1.2) 30.0 (35.1) 3.6 (3.9) 30.3 (24.2)
EMRO/EURO 4.0 (7.3) 4.2 (13.7) 8.2 (9.6) 10.4 (11.2) 13.1 (10.5)
AMRO 1.4 (2.5) 1.6 (5.2) 3.0 (3.5) 2.9 (3.1) 4.3 (3.4)
SEARO/WPRO 19.7 (36.1) 24.5 (79.9) 44.2 (51.8) 76.0 (81.8) 77.4 (61.8)
Global 54.7 30.6 85.3 92.9 125.2
Similar tables with risk estimates by continent and by pregnancy outcome (live-birth, induced abortions, stillbirths, and miscarriages) are provided in Tables S1, S2, S3.
aIncludes countries where P. falciparum and P. vivax co-exist.
bStable transmission, $1 autochthonous P. falciparum cases per 10,000 people per annum; unstable transmission, ,1 autochthonous P. falciparum cases per 10,000
people per annum [15].
MEC, malaria endemic countries; TPR, total pregnancy rate; WHORO, World Health Organization Regional Office.
doi:10.1371/journal.pmed.1000221.t003
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in 2007 approximately 125 million pregnancies occurred in areas
with P. falciparum and/or P. vivax transmission, resulting in 83
million live births; representing approximately 60% of all
pregnancies globally. Approximately 85 million pregnancies
occurred in areas with P. falciparum transmission and 93 million
in areas with transmission of P. vivax transmission, of which about
53 million occurred in areas where both species co-exist. The
pregnancies at risk estimates for P. falciparum and P. vivax in Africa
(32 million [30 million in the WHO-AFRO region]) are consistent
with the previous estimates by WHO (25–30 million). By contrast,
the numbers at risk outside Africa are much higher (95 million)
than previously estimated (25 million). Comparisons between the
estimates produced in this study and the previous WHO estimates
are made difficult because details of the methodology used by the
WHO is not provided and it is not clear if they included all
transmission areas or only areas with stable malaria transmission.
Inclusion of only those areas with stable P. falciparum transmission
in our study resulted in global risk estimates of just less than 55
million pregnancies, 31 million in Africa and 23 million in the
other regions, i.e., very similar to the previous WHO estimates.
Figure 1. Malaria risk map for P. falciparum and corresponding number of pregnancies in each continent in 2007.
doi:10.1371/journal.pmed.1000221.g001
Figure 2. Malaria risk map for P. vivax and corresponding number of pregnancies in each continent in 2007.
doi:10.1371/journal.pmed.1000221.g002
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However, the numbers of pregnancies at risk outside Africa
increase almost 4-fold if areas with unstable P. falciparum
transmission are included (clinical incidence ,1 per 10,000
population/year) (30 million) and areas situated in the temperate
regions outside the limits of P. falciparum transmission that have P.
vivax transmission only (40 million) are also included. It is also not
clear if the previous WHO estimates included pregnancies
resulting in live births only or included adjustments for induced
abortions or spontaneous pregnancy loss. Since only approxi-
mately two-thirds of all pregnancies result in live births, estimates
Table 4. Number of live-births born to pregnancies at risk of at risk of P. falciparum and/or P. vivax malaria by WHO regional office
in 2007 (in millions) (column %).
WHORO Region P. falciparum Transmissiona P. vivax Transmissiona Any Species
Stable Transmissionb Unstable Transmissionb Overall Overall Overall
AFRO 21.6 (56.7) 0.3 (1.3) 21.8 (37.4) 2.5 (4.3) 22.1 (26.7)
EMRO/EURO 2.8 (7.3) 2.9 (14.1) 5.6 (9.7) 7.1 (12.0) 9.0 (10.9)
AMRO 0.8 (2.2) 1.0 (5.0) 1.8 (3.2) 1.8 (3.1) 2.7 (3.3)
SEARO/WPRO 12.9 (33.8) 16.1 (79.5) 28.9 (49.7) 48.0 (80.6) 48.8 (59.1)
Global 38.0 20.2 58.2 59.5 82.6
Similar tables with risk estimates by continent and by pregnancy outcome (live-birth, induced abortions, stillbirths, and miscarriages) are provided in Tables S1, S2, S3.
aIncludes countries where P. falciparum and P. vivax co-exist.
bStable transmission, $1 autochthonous P. falciparum cases per 10,000 people per annum; unstable transmission, ,1 autochthonous P. falciparum cases per 10,000
people per annum [15].
MEC, malaria endemic countries; TPR, total pregnancy rate; WHORO, World Health Organization Regional Office.
doi:10.1371/journal.pmed.1000221.t004
Figure 3. Distribution of the number of pregnancies in areas with P. falciparum malaria in 2007 by WHO regions and the
corresponding proportion living under stable versus unstable transmission. Blue, SEARO and WPRO; green, AFRO; orange, EMRO; red,
AMRO.
doi:10.1371/journal.pmed.1000221.g003
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that include all pregnancies are about one-third higher than
estimates based on live births only.
Although risk estimates are widely quoted figures, it is important
to place them in perspective. The estimates provided here merely
define the global distribution of pregnancies that occur within the
global spatial limits of malaria transmission. These estimates
therefore represent ‘‘any risk’’ of exposure to malaria during
pregnancy, and do not represent the distribution of actual
incidence or health burden on mothers and unborn babies, which
is beyond the scope of this paper. More than half (71 million) of
the 125 million pregnancies occur in areas with unstable P.
falciparum transmission (31 million) or with transmission of P. vivax
only (40 million), and the risk of acquiring malaria in these areas is
extremely low. Thus, although these 71 million pregnancies
represent more than 50% of the global number of pregnancies at
risk, they may only contribute a small proportion to the number of
infections in pregnancy. For example, if the actual incidence of
malaria infection in these very low transmission areas is 1 in
10,000 per person-year (52 wk), and if the average pregnancy
resulting in a live birth takes 38 wk from fertilisation to term, then
71 million pregnancies at risk may result in only 5,188 actual
malaria infections, whereas in areas with infection rates of 1.36 or
higher per person-year, all term pregnancies have been potentially
exposed to malaria. Furthermore, the definition of stable
transmission for P. falciparum used included all areas with more
than one clinical case per 10,000 population per year. This
included almost all pregnancies at risk in the AFRO Region (99%
of the 30 million pregnancies at risk) and 25 million of the 95
million (26%) pregnancies in the other WHO regions. However,
these stable transmission strata cover a very wide range of
transmission intensities and the actual risk of infection to the 55
million individuals and the impact on maternal and infant health
varies enormously within this range.
At the higher end of the transmission spectrum, the majority of
malaria infections in pregnancy remain asymptomatic or pauci-
symptomatic, yet are a major cause of severe maternal anaemia
and preventable low birth weight, especially in the first and second
pregnancies. In areas with stable, but low transmission, and
certainly in areas with unstable and exceptionally low transmis-
sion, infections can become severe in all gravidae groups because
most women of childbearing age in these regions have low levels of
pre-pregnancy and pregnancy-specific protective immunity to
malaria [30]. The most recent version of the World Malaria Map
[28] from the Malaria Atlas Project shows that 89% of the
Figure 4. Distribution of the number of pregnancies in malaria endemic areas in 2007 by WHO regions and by species (P. vivax
transmission only, P. falciparum transmission only or transmission of both species). Blue, SEARO and WPRO; green, AFRO; orange, EMRO;
red, AMRO. Pv, P. vivax; Pf, P. falciparum.
doi:10.1371/journal.pmed.1000221.g004
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populations in stable P. falciparum areas outside Africa live in areas
characterised by low malaria endemicity (defined as P. falciparum
parasite rate in children 2–10 y of age of#5%). This total includes
all of the stable P. falciparum transmission areas in the Americas,
and 88% of the populations at risk in the Central and South-East
Asia-Pacific region [31]. Our estimates do not take seasonality into
account and include all pregnancies occurring throughout the
year, whereas those pregnancies that occur outside of the
transmission season may be at no risk, or very low risk of exposure.
Our risk estimates for P. vivax are likely to be less accurate than
those for P. falciparum because of greater uncertainties about the
basic biology of transmission and clinical epidemiology. For
example, the climatic constraints on P. vivax transmission are less
well defined, the accuracy of clinical reporting of P. vivax in areas
with coincidental P. falciparum is poor, and the untreated
hypnozoite stage of P. vivax, which can remain dormant in
infected liver cells for months or years, provides an additional
challenge to the interpretation of prevalence and incidence data
[15]. We used a refined P. vivax risk map that resulted in a 19%
increase over previous population at risk estimates (adjusted for
population growth) [18,19], principally resulting from the
removal of the population density masks and thereby the
inclusion of many large cities. In most of these cities, pregnancies
will be at low or very low risk of autochthonous infections.
Imported malaria associated with travel to rural areas may be a
greater risk factor in these cities. We did not consider infections
with P. ovale or P. malariae, as their distribution is not well
described and the adverse effects on maternal health and the
newborn infant are unknown.
In the current analysis we used the map of the global spatial
limits of P. falciparum malaria, which stratifies the malaria endemic
world by stable and unstable transmission published in 2008
[15].This map uses a simple divide between very low risk and
higher transmission intensities and a crude proxy to account for
the corresponding levels of acquired immunity in women of
childbearing age. As a next step, we will examine the burden of
malaria in pregnancy in terms of health impact on the pregnant
women (e.g., febrile episodes, impact on maternal anaemia and
maternal mortality), the newborn baby (e.g., impact on the
frequency of preterm births and low birth-weight) and the infant
(e.g., susceptibility to malaria). For this project, we will use the
more refined P. falciparum transmission intensity model of risk
within the defined stable limits which was developed recently by
the Malaria Atlas Project [31], allowing disease impact calcula-
tions across multiple transmission strata to be made. It is also
important to take the different pregnancy outcomes into account
in these further burden estimates. Of the 125 million pregnancies,
one in five are estimated to be terminated voluntarily during the
period of risk for miscarriage, and only about two-thirds (82.6
millions) are expected to result in live births. Although malaria in
pregnancy is associated with miscarriages and stillbirths [30], the
majority of the health and economic burden is likely through the
impact on pregnancies that result in live births by increasing the
risk of preterm births and low birth-weight [30] and by modifying
the susceptibility to malaria in the infant [32–34].
Most of the existing research and policy guidance for malaria
control in pregnancy has focussed on P. falciparum in the stable
transmission regions of sub-Saharan Africa. The results of this
study are consistent with the previous WHO-RBM risk estimates
for areas with stable P. falciparum malaria in Africa, but our work
offers advancement on the existing risk estimates for malaria
endemic countries outside Africa. In these regions, the burden of
malaria in pregnancy is less well defined, both in terms of the
number of pregnancies and its actual impact on health. Policy
guidelines for malaria control in pregnancy are also less well
developed for these regions.
These estimates of the number of pregnancies at risk of malaria
provide a first step towards a spatial map of the burden of malaria
in pregnancy and a more informed platform with which to
estimate the associated disease and economic impact and its
geographical distribution. Such global estimates provide guidance
in terms of priority setting for resource allocation for both research
and policy for the control of malaria in pregnancy. This project
provides a dynamic framework that allows risk estimates to be
updated when new risk maps of P. falciparum and P. vivax become
available as the world attempts to move towards malaria
elimination and eradication.
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Editors’ Summary
Background. Malaria, a mosquito-borne parasitic disease, is
a major global public-health problem. About half of the
world’s population is at risk of malaria, which kills about one
million people every year. Most of these deaths are caused
by Plasmodium falciparum, which thrives in tropical and
subtropical regions. However, the most widely distributed
type of malaria is P. vivax malaria, which also occurs in
temperate regions. Most malaria deaths are among young
children in sub-Saharan Africa, but pregnant women and
their unborn babies are also very vulnerable to malaria.
About 10,000 women and 200,000 babies die annually
because of malaria in pregnancy, which can cause
miscarriages, preterm births, and low-birth-weight births.
Over the past decade, a three-pronged approach has been
developed to prevent and control malaria in pregnancy. This
approach consists of intermittent preventative treatment of
pregnant women with antimalarial drugs, the use of
insecticide-treated bed nets to protect pregnant women
from the bites of infected mosquitoes, and management of
malarial illness among pregnant women.
Why Was This Study Done? This strategy has begun to
reduce the burden of malaria among pregnant women and
their babies but the resources available for its introduction
are very limited in many of the developing countries where
malaria is endemic (always present). Policy makers in these
countries need to know the number of pregnancies at risk of
malaria so that they can use their resources wisely. However,
although the World Health Organization recently estimated
that more than 30 million African women living in malaria
endemic areas become pregnant and are at risk for malaria
each year, there are no comprehensive and contemporary
estimates of the number of pregnancies at risk of malaria for
endemic areas outside Africa. In this study, the researchers
derive global estimates of the number of women who
became pregnant in 2007 in areas with P. falciparum and P.
vivax transmission.
What Did the Researchers Do and Find? The researchers
estimated the sizes of populations at risk of malaria in 2007
by combining maps of the global limits of P. vivax and P.
falciparum transmission with data on population densities.
They used data from various sources to calculate the annual
number of pregnancies (the sum of live births, induced
abortions, miscarriages, and still births) in each country.
Finally, they calculated the annual number of pregnancies at
risk of malaria in each country by multiplying the number of
pregnancies in the entire country by the fraction of the
population living within the spatial limits of malaria
transmission in that country. In 2007, they calculate, 125.2
million pregnancies occurred in areas with P. falciparum and/
or P. vivax transmission. These pregnancies—60% of all
pregnancies globally—resulted in 82.6 million live births.
77.4 million at-risk pregnancies occurred in Southeast Asia
and the Western Pacific (India had the most pregnancies at
risk of both P. falciparum and P. vivax malaria), 30.3 million in
Africa, 13.1 million in Europe and the Eastern Mediterranean,
and 4.3 million in the Americas. 54.7 million at-risk
pregnancies occurred in regions with stable P. falciparum
transmission (more than one case of malaria per 10,000
people per year), whereas 70.5 million occurred in areas with
low malaria transmission or P. vivax transmission only.
What Do These Findings Mean? These findings are the
first contemporary estimates of the global distribution of the
number of pregnancies at risk of P. falciparum and P. vivax
malaria. They do not provide any information on the actual
incidence of malaria during pregnancy or the health burden
on mothers and unborn babies. They simply represent ‘‘any
risk’’ of exposure. So, for example, the researchers calculate
that only about 5,000 actual malaria infections may occur
annually among the 70.5 million at-risk pregnancies in areas
with very low malaria transmission or with P. vivax
transmission only. Furthermore, these findings do not allow
for the seasonality of malaria—pregnancies that occur
outside of the transmission season may be at no or very
low risk of malaria. Nevertheless, the estimates reported in
this study are an important first step towards a spatial map
of the burden of malaria in pregnancy and should help policy
makers allocate resources for research into and control of
this important public-health problem.
Additional Information. Please access these Web sites via
the online version of this summary at http://dx.doi.org/10.
1371/journal.pmed.1000221.
N Information is available from the World Health Organiza-
tion on malaria and on malaria in pregnancy (in several
languages)
N The US Centers for Disease Control and Prevention also
provides information on malaria and on malaria in
pregnancy (in English and Spanish)
N Information is available from the Roll Back Malaria
Partnership on all aspects of global malaria control,
including information on malaria in pregnancy
N The Malaria in Pregnancy Consortium is undertaking
research into the prevention and treatment of malaria in
pregnancy and also provides a comprehensive biblio-
graphic database of published and unpublished literature
relating to malaria in pregnancy
N The Malaria Atlas Project provides maps of malaria
transmission around the world
N MedlinePlus provides links to additional information on
malaria (in English and Spanish)
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